BORDONARO, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 135
AS - Asia 99
EU - Europa 56
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 4
AF - Africa 3
Totale 313
Nazione #
US - Stati Uniti d'America 131
SG - Singapore 40
CN - Cina 27
IT - Italia 24
SE - Svezia 15
HK - Hong Kong 10
VN - Vietnam 10
FR - Francia 6
AT - Austria 5
DE - Germania 5
ID - Indonesia 5
BR - Brasile 3
CA - Canada 3
IN - India 3
AE - Emirati Arabi Uniti 1
AO - Angola 1
AR - Argentina 1
EG - Egitto 1
FI - Finlandia 1
IQ - Iraq 1
KE - Kenya 1
MN - Mongolia 1
NI - Nicaragua 1
TR - Turchia 1
Totale 297
Città #
San Jose 28
Ashburn 11
Hong Kong 10
Council Bluffs 9
Singapore 9
Ho Chi Minh City 4
Turin 4
Vienna 4
Beijing 3
Milan 3
Phoenix 3
Abbeville 2
Bologna 2
Hanoi 2
Hillsboro 2
Marseille 2
Messina 2
Naples 2
Ajman 1
Asheville 1
Bandung 1
Banyuwangi 1
Bemidji 1
Bientina 1
Birmingham 1
Bridgeton 1
Buffalo 1
Cairo 1
Chandigarh 1
Chennai 1
Chesapeake 1
Chicago 1
Corona 1
Denpasar 1
Des Moines 1
Frankfurt am Main 1
Garbagnate Milanese 1
Garden Grove 1
Haiphong 1
Hartford 1
Helsinki 1
Hải Dương 1
Inajá 1
Indianapolis 1
Jackson 1
Jakarta 1
Joinville 1
Lake Worth 1
Lakeland 1
Lexington 1
Louisville 1
Luanda 1
Managua 1
Manassas 1
Martinsville 1
Memphis 1
Mersin 1
Milwaukee 1
Montreal 1
New Orleans 1
New York 1
Newark 1
Nixa 1
North Hollywood 1
Onalaska 1
Orem 1
Piscataway 1
Plano 1
Port Allen 1
Princeton 1
Pune 1
Quảng Ngãi 1
Reston 1
Roseville 1
Río Gallegos 1
Santa Clara 1
Stockton 1
Stony Brook 1
Surabaya 1
São Paulo 1
Toronto 1
Ulan Bator 1
West Palm Beach 1
Wichita 1
Williamston 1
Totale 169
Nome #
Assessing awareness and knowledge of Human Papilloma virus infection in high school studente 33
Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study. 31
Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study. 29
Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department 24
THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES 22
PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG 21
A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival 21
Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture. 21
Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16 19
5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial 19
Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice 18
The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience 16
Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC) 14
Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire. 13
Tromboembolismo in oncologia medica 12
Totale 313
Categoria #
all - tutte 1.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026214 0 0 0 18 39 52 12 37 23 24 6 3
2026/202799 3 10 46 40 0 0 0 0 0 0 0 0
Totale 313